Development and utilization of the rat lymphocyte hprt mutation assay.
Much of the recent progress in the field of genetic toxicology has come from an increased understanding of the molecular and cellular biology of the mammalian organism. Most prominent has been the ability to detect and quantify somatic mutation and relate the nature of the mutation to the specific type of chemical damage. Building upon the foundation of the human lymphocyte hypoxanthine guanine phosphoribosyl transferase (hprt) system, and later, the mouse hprt system, methods for the detection and quantification of hprt mutations in rat lymphocytes were developed. These methods are described in this report as is the ongoing validation of the assay. Additionally, the characterization of the recovered mutants and a comparison of the mutation spectrum in the rat lymphocyte system to the spectrum in cancer genes, such as H-ras and p53, and the spectrum in transgenic systems, such as lacI, are included. The development of the rat lymphocyte hprt system and validation of the assay at the molecular level, provide an effective and reliable measure of genetic damage in an in vivo system which is readily comparable to measurement of genetic damage in the human.
Aidoo
A
A
Department of Health and Human Services, Food and Drug Administration, National Center for Toxicological Research, Jefferson, AR 72079, USA. baidoo@nctr.fda.gov
Morris
S M
SM
Casciano
D A
DA
D000818:Animals; D002478:Cells, Cultured; D018736:DNA Adducts / Q000032:analysis; D007041:Hypoxanthine Phosphoribosyltransferase / Q000235:genetics*; D008214:Lymphocytes; D009153:Mutagens / Q000633:toxicity; D009154:Mutation; D051381:Rats; D018675:Toxicity Tests / Q000379:methods
D018736:DNA Adducts; D009153:Mutagens; D007041:Hypoxanthine Phosphoribosyltransferase